Reported by DallasNews 59 minutes ago.

Graduate students are used to sleepless nights. But they typically have school work to blame, not major legislative actions that threaten to undermine their financial future.  A provision in the House version of the Republican-backed tax reform bill working its way through Congress would greatly increase the amount of taxes graduate students owe the IRS. Also at risk: thousands of U.S. universities with budgets — a major research projects — that depend on healthy graduate-student enrollments. The… Reported by bizjournals 2 hours ago.

Confirms 14 New Stores in 2017 and Strong 2018 Pipeline 
New Store Format Expands Unit Potential By 10% to 20%   

DALLAS, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Dave & Buster's Entertainment, Inc., (NASDAQ:PLAY), ("Dave & Buster's" or "the Company"), an owner and operator of entertainment and dining venues, today announced financial results for its third quarter 2017, which ended on October 29, 2017.*Key highlights from the third quarter 2017 compared to the third quarter 2016 include:*

· Total revenues increased 9.3% to $250.0 million from $228.7 million.
· Opened one new store compared to two new stores.
· Comparable store sales decreased 1.3%.
· Comparable store sales in Amusements increased 1.1% and in Food & Beverage decreased 4.2%.
· Net income of $12.2 million, or $0.29 per diluted share, vs. net income of $10.8 million, or $0.25 per diluted share.
· EBITDA increased 9.8% to $45.6 million from $41.5 million.
· EBITDA margin was flat at 18.2%.  
· Hurricanes during the quarter had an unfavorable impact on our comparable store sales growth, total revenue and EBITDA of approximately 50 basis points, $2 million and $0.7 million respectively. In addition, wildfires had an unfavorable impact on our California stores.

“Our team pulled through remarkably well in the face of unprecedented weather-related challenges in the quarter and difficult comparisons to last year. We continue to believe that the primary growth driver for the business is opening new stores with great returns. Our 2016 class of stores is trending very well, with returns close to 50%, in line with the first year returns for our recent classes of stores. While it is still early, we are also pleased with the results from our 2017 store openings, which reaffirms the concept’s broad based appeal. We continue to expect to open fourteen new stores this year, representing 15% unit growth. In addition, we are excited to announce a new smaller store format that expands our brand potential and extends our growth runway,” said Steve King, Chief Executive Officer.

“We delivered another quarter of strong financial performance despite significant hurricane headwinds. Both revenue and EBITDA increased over 9% and excluding the impact of weather would have been up low double digits. We are also very pleased with our operating team's focus on execution, which enabled us to maintain EBITDA margins, despite a slight decline in our comparable store sales, while also improving the guest experience,” said Brian Jenkins, Chief Financial Officer.

*Share Repurchase Activity *

Year-to-date, as of November 30, 2017, we had repurchased approximately 2.1 million shares of our common stock for $123.4 million and cumulatively we have repurchased 2.6 million shares for $152.2 million. As of the same date, we still had nearly $147.8 million remaining under our current buyback authorization.  

*Hurricanes and California Wildfires*

During the third quarter, our stores in the Texas markets affected by hurricane Harvey and in the Florida markets affected by hurricane Irma remained closed for several days. In addition, we delayed our Puerto Rico store opening following hurricane Maria. We estimate these hurricanes had an unfavorable impact of approximately 50 basis points on our comparable store sales growth, $2 million on total revenue and $0.7 million on EBITDA. Separately, wildfires had an unfavorable impact on our California stores.

*Review of Third Quarter 2017** **Operating Results Compared to Third Quarter 2016*

Total revenues increased 9.3% to $250.0 million from $228.7 million in the third quarter 2016. Across all stores, Food and Beverage revenues increased 6.3% to $107.7 million from $101.3 million and Amusement and Other revenues increased 11.8% to $142.3 million from $127.3 million. Food and Beverage represented 43.1% of total revenues while Amusements and Other represented 56.9% of total revenues in the third quarter 2017. In last year’s third quarter, Food & Beverage represented 44.3% of total revenues while Amusements and Other represented 55.7% of total revenues.

Comparable store sales decreased 1.3% in the third quarter 2017 compared to a 5.9% increase in the same period last year. Our comparable store sales performance was driven by a 0.9% decrease in walk-in sales and a 4.8% decrease in special events sales. Comparable store sales in Amusements and Other increased 1.1% and in Food & Beverage decreased 4.2%. Non-comparable store revenues increased $22.9 million in the third quarter 2017 to $52.4 million.

Operating income increased to $19.9 million in the third quarter of 2017 from $18.7 million in last year's third quarter. As a percentage of total revenues, operating income decreased 20 basis points to 8.0% from 8.2%.

Net income increased to $12.2 million, or $0.29 per diluted share (42.3 million diluted share base). Fully diluted earnings per share, excluding the $0.03 per share favorable impact of ASU 2016-09, and the $0.01 per share unfavorable impact of debt refinance, was $0.27. This compared to net income of $10.8 million, or $0.25 per diluted share (43.3 million diluted share base), in the same period last year.   

EBITDA increased 9.8% to $45.6 million in the third quarter 2017 from $41.5 million in the same period last year. As a percentage of total revenues, EBITDA was 18.2% in this year’s third quarter as well as in the comparable period last year.

Store operating income before depreciation and amortization increased 8.5% to $64.6 million in the third quarter 2017 from $59.6 million in last year's third quarter. As a percentage of total revenues, Store operating income before depreciation and amortization decreased 20 basis points to 25.9% from 26.1%.  

*Development*

In fiscal 2017, we intend to open fourteen new stores, including ten large and four small store formats. We currently have eleven stores under construction. We opened one store during the third quarter in Pineville, North Carolina. During the fourth quarter, we have already opened four stores in Brandon (Tampa), Florida; Woodbridge, New Jersey; Auburn, Washington; and White Marsh (Baltimore), Maryland. New Jersey and Washington are new states for us. We plan to open one additional store in Bayamon, Puerto Rico in mid-January. For the fiscal year, eight out of the fourteen new stores will be in new markets for our brand.

Total capital additions (net of tenant improvement allowances) during fiscal 2017 are now expected to be $195 million to $200 million, up from prior guidance of $182 million to $192 million, reflecting our 2017 new store openings as well as a strong 2018 pipeline.   

In fiscal 2018, we plan to open a total of fourteen to fifteen new stores, representing unit growth of 13% to 14%. These openings will skew towards the large store format and existing markets for our brand.

We are excited to announce today a new smaller store format of 15,000 to 20,000 square feet to capitalize on demand in smaller markets not included in our original plan. Long term, we see potential to open 20 to 40 of these stores, including two that are part of our 2018 plan. This new format has the potential to expand our whitespace opportunity by 10% to 20% beyond the original target of 211 locations in the United States and Canada alone.   

*Financial Outlook*

We are updating our financial outlook on several key metrics for fiscal 2017, which includes 53 weeks and ends on February 4, 2018:

· Total revenues of $1.148 billion to $1.155 billion (vs. $1.160 billion to $1.170 billion previously).
-- Primarily driven by the impact of hurricanes, including a delay in our Puerto Rico opening; and reduced comparable store sales guidance
· Comparable store sales increase of 0.0% to 0.75% (on a comparable 52-week basis) (vs. 1% to 2% previously)
· 14 new stores
· Pre-opening expenses of approximately $23 million (vs. $21 million previously)
· Net income of $110 million to $112 million (vs. $109 million to $113 million previously)
· EBITDA of $268 million to $272 million (compared to $270 million to $276 million previously)
· Diluted share count of approximately 42.6 million (vs. 42.6 million to 42.8 million previously) (including the year-to-date impact of ASU 2016-09)
· Effective tax rate of 29.5% to 30.0% (compared to 30.5% to 31.0% previously)
-- Effective tax rate and net income guidance for full year 2017 includes an $11.4 million reduction in our year-to-date provision for income taxes resulting from the implementation of ASU 2016-09. The requirements of this standard will likely further reduce our effective tax rate depending on future stock option exercises. Our guidance excludes any potential future impacts of ASU 2016-09 on our effective tax rate

For fiscal 2018, we expect low-double-digit growth in revenue and high-single-digit to low-double-digit growth in EBITDA on a comparable 52-week basis. We plan to give more comprehensive guidance for next year on our fourth quarter 2017 conference call, which is expected in early April 2018.

*Conference Call Today*

Management will hold a conference call to discuss these results today at 4:00 p.m. Central Time (5:00 p.m. Eastern Time). The conference call can be accessed over the phone by dialing (323) 794-2551 or toll-free (800) 239-9838.  A replay will be available after the call for one year beginning at 7:00 p.m. Central Time (8:00 p.m. Eastern Time) and can be accessed by dialing (412) 317-6671 or toll-free (844) 512-2921; the passcode is 9864852.

Additionally, a live and archived webcast of the conference call will be available at www.daveandbusters.com under the Investor Relations section.

*About Dave & Buster’s Entertainment, Inc.*

Founded in 1982 and headquartered in Dallas, Texas, Dave & Buster's Entertainment, Inc., is the owner and operator of 105 venues in North America that combine entertainment and dining and offer customers the opportunity to "Eat, Drink, Play and Watch," all in one location.  Dave & Buster's offers a full menu of "Fun American New Gourmet" entrées and appetizers, a full selection of alcoholic and non-alcoholic beverages, and an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events.  Dave & Buster's currently has stores in 36 states and Canada.

*Forward-Looking Statements*

The statements contained in this release that are not historical facts are forward-looking statements. These forward-looking statements involve risks and uncertainties and, consequently, could be affected by our level of indebtedness, general business and economic conditions, the impact of competition, the seasonality of the company's business, adverse weather conditions, future commodity prices, guest and employee complaints and litigation, fuel and utility costs, labor costs and availability, changes in consumer and corporate spending, changes in demographic trends, changes in governmental regulations, unfavorable publicity, our ability to open new stores, and acts of God.  Accordingly, actual results may differ materially from the forward-looking statements, and the Company therefore cautions you against relying on such forward-looking statements.  Dave & Buster's intends these forward-looking statements to speak only as of the time of this release and does not undertake to update or revise them as more appropriate information becomes available, except as required by law.

*Non-GAAP Measures*

To supplement its consolidated financial statements, which are prepared and presented in accordance with GAAP, the Company uses the following non-GAAP financial measures: EBITDA, EBITDA margin, Adjusted EBITDA, Adjusted EBITDA margin, Store operating income before depreciation and amortization, and store operating income before depreciation and amortization margin (collectively the "non-GAAP financial measures"). The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. The Company uses these non-GAAP financial measures for financial and operational decision making and as a means to evaluate period-to-period comparisons. The Company believes that they provide useful information about operating results, enhance the overall understanding of our operating performance and future prospects, and allow for greater transparency with respect to key metrics used by management in its financial and operational decision making.  The non-GAAP measures used by the Company in this press release may be different from the measures used by other companies.

 
*DAVE & BUSTER'S ENTERTAINMENT, INC.*
*Condensed Consolidated Balance Sheets*
*(in thousands)*
* *
*ASSETS*   *October 29, 2017*   *January 29, 2017*
    (unaudited)   (audited)
Current assets:        
         
Cash and cash equivalents $ 15,258   $ 20,083
Other current assets   63,855     55,521
         
Total current assets   79,113     75,604
         
Property and equipment, net   686,858     606,865
         
Intangible and other assets, net   371,226     370,264
         
Total assets $ 1,137,197   $ 1,052,733
         
         
*LIABILITIES AND STOCKHOLDERS' EQUITY*        
         
Total current liabilities $ 207,127   $ 177,797
         
Other long-term liabilities   204,580     178,856
         
Long-term debt, net   299,940     256,628
         
Stockholders' equity   425,550     439,452
         
Total liabilities and stockholders' equity $ 1,137,197   $ 1,052,733
         

  *DAVE & BUSTER'S ENTERTAINMENT, INC.*
  *Consolidated Statements of Operations (Unaudited)*
  *(in thousands, except share and per share amounts)*
  * * * * * * * * * * * * * * * * * *
      *13 Weeks Ended*   *13 Weeks Ended*
      *October 29, 2017*   *October 30, 2016*
                   
  Food and beverage revenues $ 107,690   43.1 %   $ 101,343     44.3 %
  Amusement and other revenues   142,289   56.9 %     127,316     55.7 %
  Total revenues   249,979   100.0 %     228,659     100.0 %
                   
  Cost of food and beverage (as a percentage of food and beverage revenues)     28,387   26.4 %     26,560     26.2 %
  Cost of amusement and other (as a percentage of amusement and other revenues)     16,220   11.4 %     15,581     12.2 %
  Total cost of products     44,607   17.8 %     42,141     18.4 %
  Operating payroll and benefits   57,967   23.2 %     55,034     24.1 %
  Other store operating expenses   82,766   33.1 %     71,888     31.4 %
  General and administrative expenses   13,432   5.4 %     13,506     5.9 %
  Depreciation and amortization expense   25,672   10.3 %     22,864     10.0 %
  Pre-opening costs   5,609   2.2 %     4,553     2.0 %
  Total operating costs   230,053   92.0 %     209,986     91.8 %
                   
  Operating income   19,926   8.0 %     18,673     8.2 %
                   
  Interest expense, net   2,156   0.9 %     1,578     0.7 %
  Loss on debt refinancing     718   0.3 %     -     -  
                   
  Income before provision for income taxes   17,052   6.8 %     17,095     7.5 %
  Provision for income taxes   4,895   1.9 %     6,340     2.8 %
  Net income   $ 12,157   4.9 %   $ 10,755     4.7 %
                   
  Net income per share:                
  Basic $ 0.30       $ 0.26      
  Diluted $ 0.29       $ 0.25      
  Weighted average shares used in per share calculations:                
  Basic shares   41,077,206         42,061,235      
  Diluted shares   42,250,611         43,327,812      
                   
                   
  Other information:                
  Company-owned and operated stores open at end of period   101         88      
   
                   
  The following table sets forth a reconciliation of net income to EBITDA and Adjusted EBITDA for the periods shown:
                   
      *13 Weeks Ended*   *13 Weeks Ended*
      *October 29, 2017*   *October 30, 2016*
                   
  Net income   $ 12,157   4.9 %   $ 10,755     4.7 %
  Add back:  Interest expense, net   2,156         1,578      
  Loss on debt refinancing     718         -      
  Provision for income taxes   4,895         6,340      
  Depreciation and amortization expense     25,672         22,864      
  EBITDA   45,598   18.2 %     41,537     18.2 %
  Add back:  Loss on asset disposal   321         514      
  Share-based compensation     2,557         1,668      
  Pre-opening costs     5,609         4,553      
  Other costs     46         (5 )    
  Adjusted EBITDA   $ 54,131   21.7 %   $ 48,267     21.1 %
                   
                   
                   
  The following table sets forth a reconciliation of operating income to store operating income before depreciation and amortization for the periods shown:
                   
      *13 Weeks Ended*   *13 Weeks Ended*
      *October 29, 2017*   *October 30, 2016*
      * * * * * *   * * * * * *
  Operating income   $ 19,926   8.0 %   $ 18,673     8.2 %
  Add back:  General and administrative expenses   13,432         13,506      
  Depreciation and amortization expense     25,672         22,864      
  Pre-opening costs   5,609         4,553      
  Store operating income before depreciation and amortization $ 64,639   25.9 %   $ 59,596     26.1 %
                   

  *DAVE & BUSTER'S ENTERTAINMENT, INC.*
  *Consolidated Statements of Operations (Unaudited)*
  *(in thousands, except share and per share amounts)*
  * * * * * * * * * * * * * * * * * *
      *39 Weeks Ended*   *39 Weeks Ended*
      *October 29, 2017*   *October 30, 2016*
                   
  Food and beverage revenues $ 356,190     42.7 %   $ 326,139   44.4 %
  Amusement and other revenues   478,688     57.3 %     408,837   55.6 %
  Total revenues   834,878     100.0 %     734,976   100.0 %
                   
  Cost of food and beverage (as a percentage of food and beverage revenues)     91,562     25.7 %     83,772   25.7 %
  Cost of amusement and other (as a percentage of amusement and other revenues)     50,481     10.5 %     48,628   11.9 %
  Total cost of products     142,043     17.0 %     132,400   18.0 %
  Operating payroll and benefits   187,610     22.5 %     166,614   22.7 %
  Other store operating expenses   247,663     29.6 %     214,487   29.1 %
  General and administrative expenses   45,172     5.4 %     40,131   5.5 %
  Depreciation and amortization expense   74,447     8.9 %     65,108   8.9 %
  Pre-opening costs   14,626     1.8 %     10,390   1.4 %
  Total operating costs   711,561     85.2 %     629,130   85.6 %
                   
  Operating income   123,317     14.8 %     105,846   14.4 %
                   
  Interest expense, net   6,073     0.7 %     5,573   0.8 %
  Loss on debt refinancing     718     0.1 %     -   -  
                   
  Income before provision for income taxes     116,526     14.0 %     100,273   13.6 %
  Provision for income taxes   31,217     3.8 %     36,845   5.0 %
  Net income   $ 85,309     10.2 %   $ 63,428   8.6 %
                   
  Net income per share:                
  Basic $ 2.05         $ 1.52    
  Diluted $ 1.99         $ 1.47    
  Weighted average shares used in per share calculations:                
  Basic shares   41,521,802           41,863,932    
  Diluted shares   42,888,659           43,234,767    
                   
                   
  Other information:                
  Company-owned and operated stores open at end of period   101           88    
   
                   
  The following table sets forth a reconciliation of net income to EBITDA and Adjusted EBITDA for the periods shown:
                   
      *39 Weeks Ended*   *39 Weeks Ended*
      *October 29, 2017*   *October 30, 2016*
                   
  Net income   $ 85,309     10.2 %   $ 63,428   8.6 %
  Add back:  Interest expense, net   6,073           5,573    
  Loss on debt refinancing     718           -    
  Provision for income taxes     31,217           36,845    
  Depreciation and amortization expense     74,447           65,108    
  EBITDA   197,764     23.7 %     170,954   23.3 %
  Add back:  Loss on asset disposal   1,205           987    
  Share-based compensation     7,006           4,665    
  Pre-opening costs     14,626           10,390    
  Other costs     (329 )         68    
  Adjusted EBITDA   $ 220,272     26.4 %   $ 187,064   25.5 %
                   
                   
                   
  The following table sets forth a reconciliation of operating income to store operating income before depreciation and amortization for the periods shown:
                   
      *39 Weeks Ended*   *39 Weeks Ended*
      *October 29, 2017*   *October 30, 2016*
                   
  Operating income $ 123,317     14.8 %   $ 105,846   14.4 %
  Add back:  General and administrative expenses   45,172           40,131    
  Depreciation and amortization expense     74,447           65,108    
  Pre-opening costs   14,626           10,390    
  Store operating income before depreciation and amortization   $ 257,562     30.9 %   $ 221,475   30.1 %
                   

For Investor Relations Inquiries:

Arvind Bhatia, CFA
Dave & Buster’s Entertainment, Inc.
214.904.2202
arvind_bhatia@daveandbusters.com   Reported by GlobeNewswire 2 hours ago.

AUSTIN, Texas--(BUSINESS WIRE)--Whole Foods Market is celebrating the 12 Days of Cheese by highlighting an artisan cheese each day from Dec. 8 to 19, offering customers an excellent opportunity to try some of the highest quality cheeses available at a significant discount. Each of the selected cheeses will be 50 percent off for one day during the 12-day period. These distinctive cheeses were chosen by Whole Foods Market’s global cheese buyer with help from the company’s Certified Cheese Profess Reported by Business Wire 2 hours ago.

Five Postdoctoral Scientists Will Focus on Chronic Lyme

GREENWICH, Conn. (PRWEB) December 05, 2017

Global Lyme Alliance (GLA), the leading 501(c)(3) dedicated to conquering Lyme and other tick-borne diseases through research, education and awareness, today announced the awarding of its first-ever fellowships to five young postdoctoral scientists whose work focuses on Post-Treatment Lyme Disease Syndrome (PTLDS) or chronic Lyme.

The three-year fellowships, made possible with the support of Deborah and Mark Blackman, will support five recent Ph.D. graduates with specific interest in understanding whether persistence of the bacteria Borrelia burgdorferi, the Lyme disease pathogen, or host evasion mechanisms are responsible for the continued symptoms experienced by patients treated for Lyme disease.

“The new fellows are hard-working and brilliant young scientists with fresh ideas who will tackle the mechanistic underpinnings of PTLDS,” said Mayla Hsu, Ph.D., GLA’s director of research and grants. “We’re delighted to be able to support these researchers at the beginning of their careers.”

The five are:
George Aranjuez, Ph.D., University of Central Florida, is studying the molecular mechanisms that Borrelia uses to survive during mammalian infection and how it evades the immune system.

Ashley Groshong, Ph.D., University of Connecticut, is examining the link between Borrelia protein metabolism and its ability to form persister cells thus evading antibiotic assault.

Matthew Muramatsu, Ph.D., University of Texas-Southwestern, is exploring how the genetics of persister Borrelia differ from that of replicating bacteria. His work will focus on how the transcription signals that start the persister pathway are regulated.

Bijaya Sharma, Ph.D., Tufts University, is studying whether immune deficiency is related to continued symptoms in Borrelia-infected mice. Her work explores the genetic factors in Borrelia that underlie bacterial persistence.

Xuran Zhuang, Ph.D., University of Maryland, will use tick microinjection to study the growth of persister bacteria and its genetic pathways in samples she recovers from patients.

The “Blackman-GLA Postdoctoral Fellowships” will total $1,125, 000. Each fellow will receive $75,000 per year, for each of the three years, including travel expenses to Lyme disease conferences and an invitation to GLA’s annual closed-door scientific symposium, where they will participate in scientific discussions, present their findings and meet with program donors Deborah and Mark Blackman.

All applicants were required to submit a detailed scientific proposal for expert review. Annual reports on progress of project milestones will be required before second and final installments will be awarded.

“Supporting young researchers at the beginning of their careers shows the commitment of GLA and the Blackmans to nurture the development of a cadre of experts in the Lyme disease field,” said Scott Santarella, GLA’s CEO. “We also hope that the findings of these scientists will be potentially broadly applicable to other infectious diseases.”

In addition to the fellowships, GLA awards grants each year to researchers working on promising projects that best fulfill the organization’s goal to improve diagnostic testing and uncover more effective treatment protocols. Proposals received for the 2017-18 research grant cycle represented a broad range of interests ranging from tick ecology to co-infections, from new treatment approaches to basic biology of Borrelia infection in the mouse model, in both its acute and chronic stages. The 2017-18 grantees will be announced before the end of the year.

ABOUT GLOBAL LYME ALLIANCE
Global Lyme Alliance (GLA) is the leading 501(c)(3) dedicated to conquering Lyme disease through research, education and awareness. GLA has gained national prominence for funding the most urgent and promising research in the field, while expanding education and awareness programs for the general public and physicians. Learn more at GLA.org. Reported by PRWeb 2 hours ago.

AUSTIN, Texas, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Jones Energy, Inc. (NYSE:JONE) (“Jones Energy” or “the Company”) announced today that the Company will participate in Capital One Securities 12^th Annual Energy Conference in New Orleans, LA. Mike McConnell, Company Director and President, will present at the conference on Wednesday, December 6, 2017 at 2:00 p.m. CT. The presentation and webcast for the conference will be posted to the Company’s website at www.jonesenergy.com in the Investor Relations section.*About Jones Energy*

Jones Energy, Inc. is an independent oil and natural gas company engaged in the development and acquisition of oil and natural gas properties in the Anadarko basin of Texas and Oklahoma.  Additional information about Jones Energy may be found on the Company’s website at: www.jonesenergy.com.

Investor Contact:
Page Portas, 512-493-4834
Investor Relations Associate
Or
Robert Brooks, 512-328-2953
Executive Vice President & CFO Reported by GlobeNewswire 1 hour ago.

AUSTIN, Texas, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Continental General Insurance Company (“Continental”), an indirect wholly owned subsidiary of HC2 Holdings 2, Inc. (“HC2 Holdco”) and previously, the holder of 9,987,556 common shares (the “Shares”) in the capital of Gaming Nation Inc. (“Gaming Nation”) and warrants (the “Warrants”) issued by Gaming Nation entitling the holder to acquire, upon exercise, 28,126,068 Common Shares (“Warrant Shares”), at varying exercise prices, for a term expiring April 6, 2020, announces that, on and subject to the terms of an agreement (“Arrangement Agreement”) entered into by Gaming Nation and Orange Capital GP, LLC (“Orange Capital”) on June 26, 2017, Orange Capital has acquired from Continental all of the Shares for CAD$0.95 in cash per share and all the Warrants for CAD$0.09 in cash per warrant.Continental had entered into a voting support agreement (the “Voting Support Agreement”), dated June 26, 2017, with OC Special Opportunities Fund, LP, a private investment fund, managed by Orange Capital which proposed to acquire all of the issued and outstanding shares of Gaming Nation.

Under the Voting Support Agreement, Continental agreed to vote, at the Gaming Nation Special Meeting (described below), all of the Shares and all shares issuable upon the exercise of the Warrants in favor of a proposed plan of arrangement (the “Arrangement”) pursuant to the Arrangement Agreement.  The Arrangement was completed on November 29, 2017.

Prior to the subject transactions, assuming full exercise of the Warrants, Continental had beneficial ownership of, and control and direction over, approximately 53.2% of the outstanding Common Shares of Gaming Nation.  As a result of the completion of the Arrangement, Continental has disposed of the Shares and Warrants and has ceased to have any beneficial ownership of, or control and direction over, the Shares, the Warrants or any other securities of Gaming Nation and Continental’s security holding percentage is zero. 

The transaction was implemented by way of a plan of arrangement (the “Arrangement”) under the Business Corporations Act (Ontario) subject to shareholder approval at a special meeting of shareholders of Gaming Nation (the “Gaming Nation Special Meeting”) and the approval of the Ontario Superior Court of Justice, in addition to certain regulatory approvals and closing conditions customary for a transaction of this nature.

Continental does not have any intention to acquire additional securities of Gaming Nation.

A copy of the early warning report to be filed by Continental in connection with its entering into of the Voting Support Agreement described above will be available on SEDAR under Gaming Nation’s profile. This news release is issued under the early warning provisions of National Instrument 62-103- The Early Warning System and Related Take-Over Bid and Insider Reporting Issues of the Canadian securities legislation.

*About Continental General Insurance Company*

Continental is a corporation incorporated under the laws of Texas and its head office is located at 11001 Lakeline Blvd, Suite 120, Austin, Texas 78717.  Continental, an indirect wholly owned subsidiary of HC2 Holdings 2, Inc., is in the business of long-term care insurance.

*Contact:*

Andrew G. Backman
abackman@hc2.com
212-339-5836 Reported by GlobeNewswire 1 hour ago.

ARLINGTON, Texas (AP) A person familiar with the deal tells The Associated Press that free agent left-hander Mike Minor is close to a multiyear contract with the Texas Rangers. Reported by FOX Sports 1 hour ago.

DALLAS, TX, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Istation’s Early Math development team has been named the 2017 Product Team of the Year in the SIIA Company CODiE Awards.

Istation is an award-winning, comprehensive e-learning program used by more than 4 million students and educators around the world. The Company CODiE Awards recognize outstanding teams and individuals for their accomplishments, leadership and commitment to the industry.

“The team is honored to be recognized,” said Stephanie Noland, Math Curriculum Manager at Istation. “We do what we do because we know who the students can become. I’m grateful to work with a team of professionals that understands how our work today impacts tomorrow.”

The Early Math development team is a 16-member, cross-discipline Agile team that works together to develop early childhood math content for prekindergarten through 1st grade users. The team is successfully navigating a new way of doing business together that includes professional development and implementing new project management strategies.

The team understands that young mathematicians deserve the highest quality instructional product. In their submission, the team wrote that each member is willing to do their part to contribute to that end goal and continues to work through issues that arise and collectively find effective solutions.

 “SIIA’s 2017 Company CODiE Awards recognize the teams that are at the forefront of business innovation. These companies are shaping the future of how we conduct business, and it is truly an honor to recognize these individuals and teams through the Company CODiE Awards.” said Rhianna Collier, Vice President and Managing Director of SIIA Software & Services Division and the Technology Council of Southern California.

The Software and Information Industry Association (SIIA), the principal trade association for the software and digital content industries, announced the full slate of CODiE winners during a global web announcement on December 1.

###

 

About SIIA

SIIA is an umbrella association representing 800+ technology, data and media companies globally. Industry leaders work through SIIA’s divisions to address issues and challenges that impact their industry segments with the goal of driving innovation and growth for the industry and each member company. This is accomplished through in-person and online business development opportunities, peer networking, corporate education, intellectual property protection and government relations. Visit siia.net for more information.

About Istation

Founded in 1998 and based in Dallas, Texas, Istation (Imagination Station) has become one of the nation’s leading providers of richly animated, game-like educational technology. Winner of several national educational technology awards, the Istation program puts more instructional time in the classroom through small-group and collaborative instruction. Istation’s innovative reading, math, and Spanish programs immerse students in an engaging and interactive environment and inspire them to learn. Additionally, administrators and educators can use Istation to easily track the progress of their students, schools and classrooms. Istation now serves over 4 million students throughout the United States and several other countries.

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/b95075c0-3641-4073-bb65-7b59acb9de50

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/0da25f6d-dcf3-4e53-b943-340b2a4747c0

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/649d541d-d3a3-49cf-a7d2-7e6d0760212b

CONTACT: Molly Bryan
Istation Inc.
214-292-4904
mbryan@istation.com

Emily Ruf
SIIA
410-221-6469
eruf@siia.net Reported by GlobeNewswire 1 hour ago.

Reported by DallasNews 42 minutes ago.

The Coleman Institute announced today the addition of Dr. Daniel S. Chen to The Coleman Institute network.

RICHMOND, Va. (PRWEB) December 05, 2017

The Coleman Institute announced today the addition of Dr. Daniel S. Chen to The Coleman Institute network. Operating in Dallas, TX, Dr. Chen will be offering a full range of treatment services including Accelerated Opioid Detox, outpatient alcohol detox, Naltrexone therapy and long-term care planning to those seeking recovery in the North Texas area. The Coleman Institute is a leader in the field of opioid use disorder treatment, and is proud to welcome Dr. Chen to the team of experienced addiction treatment professionals.

Dr. Chen is board certified by the American Board of Addiction Medicine. He performs outpatient medical detoxification, buprenorphine therapy, and Vivitrol® injections for the treatment of substance use disorders. Dr. Chen believes in a whole patient approach to recovery from addiction including both medical and spiritual solutions. In addition to a focus on addiction treatment, Dr. Chen offers a number of therapies for pain management. He is a neuro-anesthesiologist with fellowship training in the pain clinic at Southwestern Medical School in Dallas and is a diplomate of the American Academy of Pain Management.

"I believe the unique detoxification services offered by The Coleman Institute are the best way to treat opioid addiction and dependence,” shares Dr. Chen. “Addiction is like gravity. If you try to escape, it just pulls you back down. This treatment offers those struggling with addiction a way out of that cycle.”

The Coleman Institute’s programs utilize medically supervised detoxification to comfortably and safely control the physical symptoms of withdrawal that can make recovery from opioid addiction especially challenging. The combination of detoxification and after-care support, including Naltrexone therapy, provides patients with a comprehensive, individualized treatment plan offering the real possibility of experiencing long-term sobriety.

Dr. Peter Coleman, founder and National Medical Director for The Coleman Institute stated, “As we work to bring evidence-based treatments to those in need, partnerships with physicians like Dr. Chen are critically important. The need for opioid use disorder treatment is growing at alarming rates, and our affiliated physicians allow us to bring hope and freedom to those suffering from opiate addiction all across the country.”

To meet Dr. Chen, visit: https://thecolemaninstitute.com/locations/dallas-texas

For more information on The Coleman Institute, or to find a location near you, visit: https://thecolemaninstitute.com/.

About The Coleman Institute:

Established in 1998 in Richmond, VA, The Coleman Institute has developed a unique and customizable approach to assisting patients in overcoming their physical dependency on drugs and then accessing the long-term support resources needed to maintain their sobriety.

Since its inception, The Coleman Institute has helped thousands of patients detoxify and recover from the effects of heroin use and other opioids such as OxyContin®, Percocet® and Vicodin®. The Coleman Institute’s treatment program enables over 98% of its patients to successfully complete their detox and begin Naltrexone therapy. Naltrexone is a non-addictive opiate blocker that helps reduce cravings while patients are building the healthy habits essential for long-term recovery.

The Coleman Institute has 14 offices nationwide. (Richmond, Atlanta, Austin, Cherry Hill, Dallas-Fort Worth, Metro Chicago, Denver, Indianapolis, Minneapolis-St. Paul, Phoenix, Seattle, Tampa, Southern California, and Northern California). Reported by PRWeb 42 minutes ago.

WHARTON, Texas--(BUSINESS WIRE)--Representatives from Woodforest National Bank, FHLB Dallas & BCL of Texas today announced $60K in grants to assist 4 businesses w/hurricane recovery. Reported by Business Wire 40 minutes ago.

One-stop shop brings quality clothing to men who wear XL sizes in Mesquite, TX.

CANTON, Mass. (PRWEB) December 05, 2017

Destination XL Group, Inc. (Nasdaq: DXLG), the leading retailer of men's XL apparel, has opened a new DXL Men’s Apparel store in Mesquite, Texas. The new store makes its home at the same location of its predecessor, Casual Male XL, at 1725 N Town East Blvd in Mesquite Crossing. DXL Men’s Apparel is a one-stop shop that caters to the clothing needs and lifestyles of men who wear waist size 38+ and size XL and up, including tall sizes, plus shoes in extended sizes and widths. Unlike Casual Male XL stores, DXL Men’s Apparel stores have everything, including great fashion brands, available under one roof to satisfy its customers’ shopping needs. Of course, the Casual Male XL shopper will still find his favorite Harbor Bay and Oak Hill clothing at the same great prices he relies upon. And no longer do guys who typically wear XL sizes have to be resigned to shopping at large department stores that carry a disappointing limited selection of styles in their sizes.

“We know that guys who typically wear XL sizes have a hard time finding high-quality clothing and styles that look great, and we’re committed to providing them with a superior solution,” said David Levin, President and Chief Executive Officer of Destination XL Group, Inc. “DXL Men’s Apparel stores offer the perfect combination of quality, selection and service in one convenient location, making shopping easy and enjoyable so all men can look and feel their best, regardless of size.”

Unique in design, DXL Men’s Apparel stores have a more spacious environment, which provides an easy shopping experience. “They are truly built with guys in mind,” Levin added. “That is precisely why we changed this Casual Male XL location into a DXL Men’s Apparel store.”

When it comes to quality and an unrivaled fit, DXL Men’s Apparel sets high standards. Whether a guy is 5’5” with a stockier frame or 6’6” with an athletic build, the challenge is to fit them both properly, so they look and feel great. This is where the higher standards come into play. DXL Men’s Apparel employs a team of technical designers and quality assurance experts who dedicate themselves every day to providing XL guys with the perfect fit. Through a series of rigorous testing well beyond industry standards, the team goes back and forth to the drawing board until they’ve created the most comfortable and perfect fit imaginable. DXL serves a variety of men with a variety of builds, and recognizes that a cookie-cutter approach to fitting them is not going to work.

The DXL Men’s Apparel store features private label brands including Harbor Bay, True Nation and Oak Hill. Designer styles from over 100 top brands add to the product assortment, including Michael Kors, Polo Ralph Lauren and Levi’s, as well as brands exclusive to DXL Men’s Apparel in XL sizes such as Reebok, Robert Graham and Brooks Brothers. DXL Men’s Apparel stores offer must-have essentials at everyday values, plus current looks for every aspect of a guy’s lifestyle.

The DXL Men’s Apparel store’s one-of-a-kind shopping experience carries through to DestinationXL.com, where customers can access an even greater selection directly from the website. They can also verify if an item is in stock at the Mesquite store or any local DXL Men’s Apparel store, and can even choose to have online purchases shipped directly to a local DXL Men’s Apparel store at no charge.

About Destination XL Group
Destination XL Group, Inc. is the largest retailer of men’s apparel in sizes XL and up, with operations throughout the United States as well as in London, England and Ontario, Canada. In addition to DXL Men’s Apparel retail and outlet stores, subsidiaries of Destination XL Group, Inc. also operate Rochester Clothing stores, Casual Male XL retail and outlet stores, and e-commerce sites, including DestinationXL.com and mobile site m.DestinationXL.com. DestinationXL.com offers a multi-channel solution similar to the DXL store experience with the most extensive selection of online products available anywhere for the XL guy. The Company is headquartered in Canton, Massachusetts, and its common stock is listed on the NASDAQ Global Market under the symbol "DXLG." Sizes start at 38” waist and XL including tall sizes, plus shoe sizes 10-16, in widths to 4E. Reported by PRWeb 32 minutes ago.

AUSTIN, Texas (AP) — Former U.S. Homeland Security Secretary Tom Ridge is out of the hospital more than two weeks after suffering a heart attack and is continuing his recovery in a Texas rehabilitation facility. A Tuesday statement issued through a family spokesman quoted Ridge saying he’s making great progress and feeling much better. The […] Reported by Seattle Times 8 minutes ago.

Former Texas Tech quarterback BJ Symons Reported by FOX Sports 1 hour ago.

*PAID CONTENT | 1-800-Flowers.com*

-Find everything you need for holiday decorating and hosting at 1-800-Flowers.com and make it a season worth celebrating-

Making it through the holidays with your reputation as a good guest and party host intact is your new goal. If the endless stream of party invites and a hankering to throw a get together of your own is making you break a sweat, we’ve got the decor tips, perfect hostess gifts, and ultimate table setting guide to get you through holidays, courtesy of 1-800-Flowers.com. 

*Holiday Decor*

There’s something magical about a home transformed from an everyday adobe into a twinkling wonderland. Whether you’re living in 450 square feet in New York City or a 5,000 square foot ranch in Texas, holiday decorations set the tone for the season and serve as a reminder that it’s time to party. Adding living plants and flowers to your decor will not only boost your mood and help you relax, according to science, but it can also spark great conversation and fond memories. Read more...

More about Supported, Holiday Party, Holiday Decorating, Hostess Gifts, and Culture Reported by Mashable 1 hour ago.

LIVERMORE, Calif., Dec. 06, 2017 (GLOBE NEWSWIRE) -- The Board of Directors of McGrath RentCorp (NASDAQ:MGRC), a diversified business to business rental company declared a quarterly cash dividend of $0.26 per common share for the quarter ended December 31, 2017.  The dividend will be payable on January 31, 2018 to all shareholders of record on January 17, 2018. The year 2017 marks the 25th consecutive year that McGrath RentCorp has raised its dividend to shareholders.

*About McGrath RentCorp*

Founded in 1979, McGrath RentCorp is a diversified business-to-business rental company with four rental divisions.  Mobile Modular rents and sells modular buildings to fulfill customers' temporary and permanent classroom and office space needs in California, Texas, Florida, and the Mid-Atlantic from Washington D.C. to Georgia.  TRS-RenTelco rents and sells electronic test equipment and is one of the leading rental providers of general purpose and communications test equipment in the Americas.  Adler Tank Rentals rents and sells containment solutions for hazardous and nonhazardous liquids and solids with operations serving key markets throughout the United States.  Mobile Modular Portable Storage provides portable storage solutions in the California, Texas, Florida, Northern Illinois, New Jersey, North Carolina and Georgia markets.  For more information on McGrath RentCorp and its operating units, please visit our websites:

Corporate – www.mgrc.com
Modular Buildings – www.mobilemodular.com
Electronic Test Equipment – www.trsrentelco.com
Tanks and Boxes – www.adlertankrentals.com
Portable Storage – www.mobilemodularcontainers.com
School Facilities Manufacturing – www.enviroplex.com

FOR INFORMATION CONTACT:Keith E. Pratt
Chief Financial Officer
925-606-9200 Reported by GlobeNewswire 1 hour ago.

Legal action based on an obscure Ohio law to keep Columbus Crew SC from leaving town would be unprecedented but could deal a blow to Precourt Sports Ventures' Texas two-step. I reached to some local attorneys Wednesday after state Rep. Mike Duffey, R-Worthington, said he planned to ask Ohio Attorney General Mike DeWine to see if a section of the Ohio Revised Code dealing with sports franchise moves could be used to stop Precourt from moving the team to Austin, Texas. Gerrod Bede, an attorney and… Reported by bizjournals 59 minutes ago.

Reported by DallasNews 55 minutes ago.

SALT LAKE CITY, Dec. 06, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced results from a ground-breaking validation study to better define the risk of breast cancer in women of European ancestry who test negative for a hereditary cancer mutation with the myRisk^® Hereditary Cancer test.  The results are being featured in a Spotlight presentation today at the 2017 San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas.  “Myriad Genetics is the first to bring to market a comprehensive approach to lifetime breast cancer risk assessment that includes 28 genes, family history evaluation, and well-validated SNPs through riskScore,” said Johnathan Lancaster, M.D., Ph.D., chief medical officer, Myriad Genetics.  “This comprehensive approach delivers the most precise tool in the industry to help physicians assess a patient’s breast cancer risk and empower choices that may prevent a patient’s breast cancer from ever happening.”A summary of this study appears below and more information about the company’s presentation can be found at: https://www.sabcs.org/2017-SABCS.  Follow Myriad on Twitter via @MyriadGenetics and stay informed about symposium news and updates by using the hashtag #SABCS17.

*myRisk^® Hereditary Cancer with riskScore™ Spotlight Presentation *
*Title:  *Development and Validation of a Combined Residual Risk Score to Predict Breast Cancer Risk in Unaffected Women Negative for Mutations on a Multi-Gene Hereditary Cancer Panel.
*Presenter:*  Elisha Hughes, Ph.D.
*Date:*  Wednesday, Dec. 6, 2017, 5:00–7:00 p.m.
*Location:  *Poster Discussion, PD1-08

This study was designed to validate the new riskScore*™* test’s ability to predict the 5-year and lifetime risk of breast cancer compared to the Tyrer-Cuzick model alone.  riskScore is a novel test that combines data from the Tyrer-Cuzick model with 86 genetic markers, called single nucleotide polymorphisms (SNPs), to comprise a combined risk score that accounts for clinical, familial and genetic variables.

The validation study included 1,617 women: 990 women with breast cancer and 627 controls.  The results show that riskScore is a highly statistically significant predictor of the 5-year and lifetime risk of breast cancer (p=5.2x10^-39 and p=4.1x10^-35, respectively).  Moreover, riskScore was statistically significantly superior to Tyrer-Cuzick alone for both 5-year and lifetime risk of breast cancer (1.0x10^-12 and 8.3x10^-13, respectively), underscoring the important contribution of the SNPs to the test.“The combination of the SNP panel with Tyrer-Cuzick provides even greater precision than previously demonstrated from family history models,” said Jerry Lanchbury, Ph.D., chief scientific officer, Myriad Genetics.  “As a result, we believe our myRisk Hereditary Cancer test, now enhanced with riskScore, provides the most comprehensive breast cancer risk assessment available today.”In a separate analysis, the riskScore test was applied to a real-world cohort of 6,479 women who tested negative for mutations in 11 genes associated with hereditary breast cancer to determine their remaining lifetime risk of developing breast cancer.  The results show that riskScore remaining lifetime risk estimates ranged from 0.88 percent to 66.4 percent (Graph 1).  Additionally, 38.2 percent of patients tested with riskScore had a lifetime risk >20 percent and 7.4 percent had a lifetime risk >3 times the general population (35 percent). 

“These data confirm the important contribution of SNPs to breast cancer risk assessment in unaffected women who test negative for mutations in hereditary breast cancer genes with a precise measure of breast cancer risk,” said Lanchbury.  “The addition of the SNP data appears to be especially helpful in identifying those patients at higher risk for developing breast cancer.”

Graph 1: http://www.globenewswire.com/NewsRoom/AttachmentNg/77414286-874b-4f88-bdae-30a43222b6db

“Patients who are above 20 percent lifetime risk are candidates for additional screening based on U.S. Preventive Services Task Force recommendations and those above 35 percent may be candidates for more aggressive medical interventions,” said Lancaster.  “Importantly, these data show that riskScore identifies a larger number of high-risk patients than either BRCA1 or BRCA2 testing and represents the next major epoch in hereditary cancer risk assessment and patient care.”

*About riskScore*
riskScore is a new clinically validated personalized medicine tool that enhances Myriad’s myRisk*^®* Hereditary Cancer test.  riskScore helps to further predict a women’s lifetime risk of developing breast cancer using clinical risk factors and genetic-markers throughout the genome. The test incorporates data from greater than 80 single nucleotide polymorphisms identified through 20 years of genome wide association studies in breast cancer and was validated in our laboratory to predict breast cancer risk in women of European descent. This data is then combined with a best-in-class family and personal history algorithm, the Tyrer-Cuzick model, to provide every patient with individualized breast cancer risk.

*About **Myriad myRisk^® Hereditary Cancer*
The Myriad myRisk Hereditary Cancer test uses an extensive number of sophisticated technologies and proprietary algorithms to evaluate 28 clinically significant genes associated with eight hereditary cancer sites including: breast, colon, ovarian, endometrial, pancreatic, prostate and gastric cancers and melanoma. 

*About Myriad Genetics*
Myriad Genetics Inc., is a leading personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics.  Myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs.  Myriad is focused on five strategic imperatives:  stabilizing hereditary cancer revenue, growing new product volume, expanding reimbursement coverage for new products, increasing RNA kit revenue internationally and improving profitability with Elevate 2020.  For more information on how Myriad is making a difference, please visit the Company's website: www.myriad.com.Myriad, the Myriad logo, BART, BRACAnalysis, Colaris, Colaris AP, myPath, myRisk, Myriad myRisk, myRisk Hereditary Cancer, myChoice, myPlan, BRACAnalysis CDx, Tumor BRACAnalysis CDx, myChoice HRD, EndoPredict, Vectra, GeneSight, riskScore and Prolaris are trademarks or registered trademarks of Myriad Genetics, Inc. or its wholly owned subsidiaries in the United States and foreign countries. MYGN-F, MYGN-G.

*Safe Harbor Statement*
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the presentation of the Company’s riskScore validation study at the 2017 San Antonio Breast Cancer Symposium; the ability of riskScore to predict 5-year and lifetime risk of breast cancer in women who test negative for hereditary breast cancer mutations; the Company’s belief that its myRisk hereditary cancer test, now enhanced with riskScore, provides the most comprehensive breast cancer risk assessment available today; the utility of the additional SNP data in identifying those patients at higher risk for developing breast cancer; the number of patients who are candidates for additional screening based on U.S. Preventive Services Task Force recommendations and the number of patients who may be candidates for more aggressive medical interventions; riskScore identifying a larger number of high-risk patients than either BRCA1 or BRCA2 testing; the Company’s belief that riskScore represents the next major epoch in hereditary cancer risk assessment and patient care; and the Company’s strategic directives under the caption “About Myriad Genetics.” These “forward-looking statements” are based on management’s current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those described or implied in the forward-looking statements. These risks include, but are not limited to: the risk that sales and profit margins of our existing molecular diagnostic tests and pharmaceutical and clinical services may decline or will not continue to increase at historical rates; risks related to our ability to transition from our existing product portfolio to our new tests; risks related to changes in the governmental or private insurers’ reimbursement levels for our tests or our ability to obtain reimbursement for our new tests at comparable levels to our existing tests; risks related to increased competition and the development of new competing tests and services; the risk that we may be unable to develop or achieve commercial success for additional molecular diagnostic tests and pharmaceutical and clinical services in a timely manner, or at all; the risk that we may not successfully develop new markets for our molecular diagnostic tests and pharmaceutical and clinical services, including our ability to successfully generate revenue outside the United States; the risk that licenses to the technology underlying our molecular diagnostic tests and pharmaceutical and clinical services tests and any future tests are terminated or cannot be maintained on satisfactory terms; risks related to delays or other problems with operating our laboratory testing facilities; risks related to public concern over genetic testing in general or our tests in particular; risks related to regulatory requirements or enforcement in the United States and foreign countries and changes in the structure of the healthcare system or healthcare payment systems; risks related to our ability to obtain new corporate collaborations or licenses and acquire new technologies or businesses on satisfactory terms, if at all; risks related to our ability to successfully integrate and derive benefits from any technologies or businesses that we license or acquire, including but not limited to our acquisition of Assurex, Sividon and the Clinic; risks related to our projections about the potential market opportunity for our products; the risk that we or our licensors may be unable to protect or that third parties will infringe the proprietary technologies underlying our tests; the risk of patent-infringement claims or challenges to the validity of our patents; risks related to changes in intellectual property laws covering our molecular diagnostic tests and pharmaceutical and clinical services and patents or enforcement in the United States and foreign countries, such as the Supreme Court decision in the lawsuit brought against us by the Association for Molecular Pathology et al; risks of new, changing and competitive technologies and regulations in the United States and internationally; the risk that we may be unable to comply with financial operating covenants under our credit or lending agreements; the risk that we will be unable to pay, when due, amounts due under our credit or lending agreements; and other factors discussed under the heading “Risk Factors” contained in Item 1A of our most recent Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as well as any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10-Q or Current Reports on Form 8-K.

Media Contact:
Ron Rogers
(908) 285-0248
rrogers@myriad.comInvestor Contact:
Scott Gleason
(801) 584-1143
sgleason@myriad.com Reported by GlobeNewswire 47 minutes ago.